Home > Financial Ratios > ONESOURCE SPECIALTY PHARMA

ONESOURCE SPECIALTY PHARMA
Core EBITDA Margin

    Back to All Ratios
ONESOURCE SPECIALTY PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for ONESOURCE SPECIALTY PHARMA
Please provide your vote to see the results

ONESOURCE SPECIALTY PHARMA Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) 32.10-51.33-415.06-3.13

What is the latest Core EBITDA Margin ratio of ONESOURCE SPECIALTY PHARMA ?

The latest Core EBITDA Margin ratio of ONESOURCE SPECIALTY PHARMA is 32.10 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar202532.10
Mar2024-51.33
Mar2023-415.06
Mar2022-3.13

How is Core EBITDA Margin of ONESOURCE SPECIALTY PHARMA Trending?

Years Core EBITDA Margin % Change
Mar2025 32.1
Positive
Mar2024 -51.33
Negative
Mar2023 -415.06
Negative
Mar2022 -3.13 -

Other Financial Ratios of ONESOURCE SPECIALTY PHARMA


Compare Core EBITDA Margin ratio of peers of ONESOURCE SPECIALTY PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA ₹20,050.7 Cr 5.7% 5.9% -11.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹477,408.0 Cr 1.8% 6.8% 17.8% Stock Analytics
DIVIS LABORATORIES ₹206,906.0 Cr 6.7% 18.5% 12.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,521.0 Cr -3.7% 5.5% 39.8% Stock Analytics
CIPLA ₹119,032.0 Cr 5.7% 0.6% -1.4% Stock Analytics
DR REDDYS LABORATORIES ₹95,420.1 Cr -2% -15.8% -8.4% Stock Analytics


ONESOURCE SPECIALTY PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA

5.7%

5.9%

-11.4%

SENSEX

1.2%

1.2%

-5.5%


You may also like the below Video Courses